Fondazione Cariplo (FC) and Fondazione Telethon (FT) invest in a joint initiative aiming at fostering basic research to support projects focused on aspects of rare diseases and announce the third round of the “Joint Call for Applications” to solicit projects focusing on the study of genes/gene families, proteins and mRNAs molecules whose function is unknown in rare diseases, of genetic and non – genetic origin.

 

Eligible projects might focus on the following genetic aspects:

• Genes associated with rare diseases whose function is completely or largely unknown
• One genotype, multiple clinical phenotypes
• Genetic modifiers

This call will not support applications focused on:

Amyotrophic lateral sclerosis (ALS), as funding opportunities for ALS are available through AriSLA (http://www.arisla.org/), a dedicated Foundation supported by FC and FT
Non-coding RNA (miRNA, lncRNA etc.)
Preliminary data are not mandatory.

 

For this Call, both Applications for single- and multiple-center proposals are admitted.

Each project will be funded with a maximum budget of 250,000 Euro.

 

Call text and guidelines are available on Foundation Cariplo (https://www.fondazionecariplo.it/it/bandi/Bandi.html) and Foundation Telethon websites (https://www.telethon.it/cosa-facciamo/ricerca/bandi-di-ricerca/joint-call-for-applications-fondazione-cariplo-e-fondazione-telethon-2023).

 

Application Submission Deadline: 27 September 2023